DBV Technologies | Betriebsaufwand





Betriebsaufwand Veränderung Datum
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Amarin USD 51.37M 14.6M 2025-09
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
DBV Technologies USD 37.05M 4.06M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Galectin Therapeutics USD 11.29M 1.64M 2024-06
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
Incyte USD 1.12B 3.53B 2025-12
Insmed USD 403.69M 42.4M 2025-09
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
Neurocrine Biosciences USD 555.6M 13.7M 2025-09
PTC Therapeutics USD 207.52M 6.21M 2025-09
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
United Therapeutics USD 6.59B 6.07B 2025-09


DBV Technologies Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.